Similar articles

• Cytochrome P450 2D6 polymorphism and character traits.

  Suzuki E, Kitao Y, Ono Y, Iijima Y, Inada T.Suzuki E, et al.Psychiatr Genet. 2003 Jun;13(2):111-3. doi: 10.1097/01.ypg.0000056175.32550.37.Psychiatr Genet. 2003.PMID:12782969
• Molecular Mechanisms Underlying Single Nucleotide Polymorphism-Induced Reactivity Decrease in CYP2D6.

  Becker D, Bharatam PV, Gohlke H.Becker D, et al.J Chem Inf Model. 2024 Aug 12;64(15):6026-6040. doi: 10.1021/acs.jcim.4c00276. Epub 2024 Jul 12.J Chem Inf Model. 2024.PMID:38994927
• Measurement of human liver microsomal cytochrome P450 2D6 activity using [O-methyl-14C]dextromethorphan as substrate.

  Rodrigues AD.Rodrigues AD.Methods Enzymol. 1996;272:186-95. doi: 10.1016/s0076-6879(96)72023-2.Methods Enzymol. 1996.PMID:8791777No abstract available.
• Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

  Zhou SF.Zhou SF.Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000.Clin Pharmacokinet. 2009.PMID:19817501Review.
• Prediction of drug metabolism: the case of cytochrome P450 2D6.

  Vermeulen NP.Vermeulen NP.Curr Top Med Chem. 2003;3(11):1227-39. doi: 10.2174/1568026033451998.Curr Top Med Chem. 2003.PMID:12769702Review.

Cited by

• The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.

  Wesmiller SW, Henker RA, Sereika SM, Donovan HS, Meng L, Gruen GS, Tarkin IS, Conley YP.Wesmiller SW, et al.Biol Res Nurs. 2013 Oct;15(4):382-9. doi: 10.1177/1099800412449181. Epub 2012 Jun 20.Biol Res Nurs. 2013.PMID:22718526Free PMC article.
• Antipsychotic drug-aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms.

  Stelmach A, Guzek K, Rożnowska A, Najbar I, Sadakierska-Chudy A.Stelmach A, et al.Pharmacol Rep. 2023 Feb;75(1):19-31. doi: 10.1007/s43440-022-00440-6. Epub 2022 Dec 16.Pharmacol Rep. 2023.PMID:36526889Free PMC article.Review.
• Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

  Qiao W, Martis S, Mendiratta G, Shi L, Botton MR, Yang Y, Gaedigk A, Vijzelaar R, Edelmann L, Kornreich R, Desnick RJ, Scott SA.Qiao W, et al.Pharmacogenomics. 2019 Jan;20(1):9-20. doi: 10.2217/pgs-2018-0135. Epub 2018 Dec 6.Pharmacogenomics. 2019.PMID:30730286Free PMC article.
• Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week.

  DeFilippis EM, Bajaj NS, Singh A, Malloy R, Givertz MM, Blankstein R, Bhatt DL, Vaduganathan M.DeFilippis EM, et al.J Am Coll Cardiol. 2020 Jan 28;75(3):320-332. doi: 10.1016/j.jacc.2019.11.025.J Am Coll Cardiol. 2020.PMID:31976871Free PMC article.Review.
• Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.

  Eum S, Lee AM, Bishop JR.Eum S, et al.Dialogues Clin Neurosci. 2016 Sep;18(3):323-337. doi: 10.31887/DCNS.2016.18.3/jbishop.Dialogues Clin Neurosci. 2016.PMID:27757066Free PMC article.Review.

References

Publication types

• Review

MeSH terms

• Animals
• Cytochrome P-450 CYP2D6 / genetics
• Cytochrome P-450 CYP2D6 / metabolism*
• Haplotypes
• Humans
• Polymorphism, Single Nucleotide / genetics
• Substrate Specificity

Substances

• Cytochrome P-450 CYP2D6

Related information

• Cited in Books
• Gene
• MedGen (Bookshelf cited)
• Protein (RefSeq)

Grants and funding

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wolters Kluwer